Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression.

Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB.

Am J Psychiatry. 2006 Apr;163(4):637-43.

PMID:
16585438
2.

Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.

Geracioti TD Jr, Baker DG, Kasckow JW, Strawn JR, Jeffrey Mulchahey J, Dashevsky BA, Horn PS, Ekhator NN.

Psychoneuroendocrinology. 2008 May;33(4):416-24. doi: 10.1016/j.psyneuen.2007.12.012. Epub 2008 Mar 4.

PMID:
18295412
3.

Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.

Bonne O, Gill JM, Luckenbaugh DA, Collins C, Owens MJ, Alesci S, Neumeister A, Yuan P, Kinkead B, Manji HK, Charney DS, Vythilingam M.

J Clin Psychiatry. 2011 Aug;72(8):1124-8. doi: 10.4088/JCP.09m05106blu. Epub 2010 Dec 28.

PMID:
21208596
4.

Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.

Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB.

Psychiatry Res. 2008 Jan 15;157(1-3):123-9. Epub 2007 Oct 31.

PMID:
17976740
5.

Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder.

Sher L, Oquendo MA, Li S, Burke AK, Grunebaum MF, Zalsman G, Huang YY, Mann JJ.

Eur Neuropsychopharmacol. 2005 Mar;15(2):203-9.

PMID:
15695066
6.

Cerebrospinal fluid and plasma beta-endorphin in combat veterans with post-traumatic stress disorder.

Baker DG, West SA, Orth DN, Hill KK, Nicholson WE, Ekhator NN, Bruce AB, Wortman MD, Keck PE Jr, Geracioti TD Jr.

Psychoneuroendocrinology. 1997 Oct;22(7):517-29.

PMID:
9373885
7.

Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression.

von Känel R, Schmid JP, Abbas CC, Gander ML, Saner H, Begré S.

J Affect Disord. 2010 Feb;121(1-2):73-9. doi: 10.1016/j.jad.2009.05.016. Epub 2009 Jun 13.

PMID:
19525012
8.

Autonomic and respiratory characteristics of posttraumatic stress disorder and panic disorder.

Blechert J, Michael T, Grossman P, Lajtman M, Wilhelm FH.

Psychosom Med. 2007 Dec;69(9):935-43. Epub 2007 Nov 8.

PMID:
17991823
9.

Blood pressure and cerebrospinal fluid norepinephrine in combat-related posttraumatic stress disorder.

Strawn JR, Ekhator NN, Horn PS, Baker DG, Geracioti TD Jr.

Psychosom Med. 2004 Sep-Oct;66(5):757-9.

PMID:
15385702
10.

Corticolimbic blood flow during nontraumatic emotional processing in posttraumatic stress disorder.

Phan KL, Britton JC, Taylor SF, Fig LM, Liberzon I.

Arch Gen Psychiatry. 2006 Feb;63(2):184-92.

PMID:
16461862
11.

Association of time since deployment, combat intensity, and posttraumatic stress symptoms with neuropsychological outcomes following Iraq war deployment.

Marx BP, Brailey K, Proctor SP, Macdonald HZ, Graefe AC, Amoroso P, Heeren T, Vasterling JJ.

Arch Gen Psychiatry. 2009 Sep;66(9):996-1004. doi: 10.1001/archgenpsychiatry.2009.109.

PMID:
19736356
12.

Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study.

Pitman RK, van der Kolk BA, Orr SP, Greenberg MS.

Arch Gen Psychiatry. 1990 Jun;47(6):541-4.

PMID:
2350206
13.

Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder.

Baker DG, Ekhator NN, Kasckow JW, Dashevsky B, Horn PS, Bednarik L, Geracioti TD Jr.

Am J Psychiatry. 2005 May;162(5):992-4.

PMID:
15863803
14.

Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder.

Yehuda R, Halligan SL, Golier JA, Grossman R, Bierer LM.

Psychoneuroendocrinology. 2004 Apr;29(3):389-404.

PMID:
14644068
15.

Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence.

Mulchahey JJ, Ekhator NN, Zhang H, Kasckow JW, Baker DG, Geracioti TD Jr.

Psychoneuroendocrinology. 2001 Apr;26(3):273-85.

PMID:
11166490
16.

CSF norepinephrine concentrations in posttraumatic stress disorder.

Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE Jr, Kasckow JW.

Am J Psychiatry. 2001 Aug;158(8):1227-30.

PMID:
11481155
17.

Trajectories of PTSD: a 20-year longitudinal study.

Solomon Z, Mikulincer M.

Am J Psychiatry. 2006 Apr;163(4):659-66.

PMID:
16585441
18.

Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder.

Sah R, Ekhator NN, Jefferson-Wilson L, Horn PS, Geracioti TD Jr.

Psychoneuroendocrinology. 2014 Feb;40:277-83. doi: 10.1016/j.psyneuen.2013.10.017. Epub 2013 Nov 5.

19.

Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder.

Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr.

Am J Psychiatry. 1999 Apr;156(4):585-8. Erratum in: Am J Psychiatry 1999 Jun;156(6):986.

PMID:
10200738
20.

Discriminative delay Pavlovian eyeblink conditioning in veterans with and without posttraumatic stress disorder.

Ginsberg JP, Ayers E, Burriss L, Powell DA.

J Anxiety Disord. 2008 Jun;22(5):809-23. Epub 2007 Aug 30.

PMID:
17913453
Items per page

Supplemental Content

Write to the Help Desk